Investment Summary |
|
|---|---|
| Date | 2007-02-27 |
| Target | Shire Regenerative Medicine |
| Sector | Life Science |
| Investor(s) | Safeguard |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Financial Services |
| Employees | 30 |
| Revenue | 6M USD (2023) |
Safeguard is a provider of capital and operational expertise to emerging and growth-stage healthcare and technology enterprises that are developing innovative products and services.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 10 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Stake Purchase M&A Deals | 2 of 5 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 4 of 10 |
| Year: 2007 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-04-25 |
SafeCentral
Palm Beach Gardens, Florida, United States SafeCentral, Inc. is a developer of core operating system encapsulation, file and application defense, data interception and data analysis technologies for inclusion in its flagship Extensible Security Platform (ESP). |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-23 |
Transactis
Charlotte, North Carolina, United States Transactis, Inc. is a provider of proprietary, patent-pending TransactMail technology that allows secure online transactions to take place directly from an email client using SSL without the need to herd the consumer over to a browser where they may become frustrated with the need to start their transaction all over again. Transactis, Inc. was founded in 2001 and is based in Charlotte, North Carolina. |
Buy | - |
